Literature DB >> 16100301

Single-dose and steady-state pharmacokinetics of eslicarbazepine acetate (BIA 2-093) in healthy elderly and young subjects.

Luis Almeida1, Amílcar Falcão, Joana Maia, Dago Mazur, Manfred Gellert, Patrício Soares-da-Silva.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16100301     DOI： 10.1177/0091270005279364

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN： 0091-2700            Impact factor:   3.126


× No keyword cloud information.
  24 in total

Review 1.  Diverse mechanisms of antiepileptic drugs in the development pipeline.

Authors:  Michael A Rogawski
Journal:  Epilepsy Res       Date:  2006-04-18       Impact factor: 3.045

2.  Functional half-life is a meaningful descriptor of steady-state pharmacokinetics of an extended-release formulation of a rapidly cleared drug : as shown by once-daily divalproex-ER.

Authors:  Sandeep Dutta; Ronald C Reed
Journal:  Clin Drug Investig       Date:  2006       Impact factor: 2.859

3.  [Abrupt switch from extended-release oxcarbazepine to eslicarbazepine acetate].

Authors:  B J Steinhoff; E Trinka; A S Wendling
Journal:  Nervenarzt       Date:  2011-06       Impact factor: 1.214

Review 4.  Eslicarbazepine acetate (BIA 2-093).

Authors:  Luis Almeida; Patrício Soares-da-Silva
Journal:  Neurotherapeutics       Date:  2007-01       Impact factor: 7.620

Review 5.  Novel medications for epilepsy.

Authors:  Cinzia Fattore; Emilio Perucca
Journal:  Drugs       Date:  2011-11-12       Impact factor: 9.546

Review 6.  Practice Update: Review of Anticonvulsant Therapy.

Authors:  Derek J Chong; Andrew M Lerman
Journal:  Curr Neurol Neurosci Rep       Date:  2016-04       Impact factor: 5.081

Review 7.  The Pharmacology and Toxicology of Third-Generation Anticonvulsant Drugs.

Authors:  Paul LaPenna; Laura M Tormoehlen
Journal:  J Med Toxicol       Date:  2017-08-16

8.  Pharmacokinetics of eslicarbazepine acetate in patients with moderate hepatic impairment.

Authors:  Luis Almeida; J Hendrick Potgieter; Joana Maia; M Alida Potgieter; Fernando Mota; P Soares-da-Silva
Journal:  Eur J Clin Pharmacol       Date:  2007-12-21       Impact factor: 2.953

9.  Role of eslicarbazepine in the treatment of epilepsy in adult patients with partial-onset seizures.

Authors:  Martin E Brown; Rif S El-Mallakh
Journal:  Ther Clin Risk Manag       Date:  2010-04-15       Impact factor: 2.423

10.  Therapeutic Drug Monitoring of the Newer Anti-Epilepsy Medications.

Authors:  Matthew D Krasowski
Journal:  Pharmaceuticals (Basel)       Date:  2010-06-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.